Cargando…
Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
INTRODUCTION: Much drug development and published analysis for epithelial ovarian cancer (EOC) focuses on early-line treatment. Full sequences of treatment from diagnosis to death and the impact of later lines of therapy are rarely studied. We describe the establishment of an international network o...
Autores principales: | Cheeseman, Sue, Levick, Bethany, Sopwith, Will, Fenton, Hayley, Nam, Eun Ji, Kim, DongKyu, Lim, Subin, Martin, Elodie, Frenel, Jean-Sébastien, Bocquet, François, Kubelac, Paul, Achimas-Cadariu, Patriciu, Vlad, Catalin, Chevrier, Marion, Rouzier, Roman, Carton, Matthieu, Savva-Bordalo, Joana, Magalhães, Marta, Borges, Marina, Wolf, Andrea, Becker, Sven, Niklas, Nicolas, Guergova-Kuras, Mariana, Hall, Geoff |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911857/ https://www.ncbi.nlm.nih.gov/pubmed/36776297 http://dx.doi.org/10.3389/fonc.2023.1114435 |
Ejemplares similares
-
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
por: Achimas-Cadariu, Patriciu, et al.
Publicado: (2022) -
Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2021) -
Antiproliferative Ruthenium Complexes Containing Curcuminoid Ligands Tested In Vitro on Human Ovarian Tumor Cell Line A2780, towards Their Capability to Modulate the NF-κBTranscription Factor, FGF-2 Growth Factor, and MMP-9 Pathway
por: Leskovská, Janka, et al.
Publicado: (2022) -
Impact of Hormone Replacement Therapy on the Overall Survival and Progression Free Survival of Ovarian Cancer Patients: A Systematic Review and Meta-Analysis
por: Achimaș-Cadariu, Patriciu Andrei, et al.
Publicado: (2023) -
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2020)